Siegfried Holding AG (SFZN) Price & Analysis

Siegfried Holding AG, a global life sciences enterprise founded in 1873 and headquartered in Zofingen, Switzerland, is actively involved in the development and manufacture of various pharmaceutical products. The company specializes in creating active pharmaceutical ingredients (APIs) and chemical intermediates. Additionally, it produces a diverse range of finished dosage forms, which include solid oral medications, sterile and aseptically filled injectable drugs, ophthalmic solutions, and inhalation therapies. Beyond manufacturing, Siegfried provides comprehensive contract development and manufacturing (CDMO) services. These offerings span from pharmaceutical and analytical development and seamless process and analytical transfer, to commercial-scale production, packaging, and the essential scale-up and production of materials for clinical trials. The company further supplies specialized APIs and controlled substances, with a particular focus on compounds used in anesthetics, pain management, and treatments for conditions affecting the central nervous system and respiratory system. Its services also encompass the licensing of oral solid and sterile pharmaceutical products, the compilation of essential registration dossiers, and the provision of Common Technical Documents (CTDs) for its varied product portfolio.